Collaboration greatly reduces cost and administrative burden in clinical research.
HealthCarePoint (HCP) and ViS Research today announced they will connect platforms to improve cost-efficiency in clinical research. The partnership will allow clinical trial planners to quickly access clinical research professionals’ Personal Experience and Training (PET) records through the ViS platform and give clinical research sites access to human resource management systems hosted by HealthCarePoint at no cost.
Sites and clinical researchers benefit from an efficient way to share their qualifications, while trial planners gain ready access to structured data for compliance and site evaluation for inclusion in trials. The number of healthcare professionals that are already holding their qualification records through HealthCarePoint's network is close to 500,000, so it is clear that the impact will be substantial.
Users of ViS' online feasibility platform, which include most large pharma companies and CROs, will have seamless and quick access to the information they need for site feasibility assessment. The functional integration of these two innovative technologies will provide a complete solution to industry sponsors, CROs, IRB representatives, and research associations who need to search, find, retrieve and maintain verifiable information on professional competencies for regulatory compliance purposes.
The collaboration aims to revamp an outdated process, which is still based on questionnaires and numerous silos of stale information. On the one hand, it eliminates the need for the cumbersome feasibility questionnaires. On the other, it allows professionals to share their portable PET records, across the industry. The end result is that the time spent conducting feasibility assessment and building records drops to hours, instead of months, and researchers save billions per year in time and resources.
“HealthcarePoint’s and ViS’ patent-pending technologies are complementary and have been proven to be a catalyst for cost-efficiency in this industry,” says Al O.Pacino, HealthCarePoint President. "Empowering researchers to exchange and dynamically share information in real time through permission-based networks will improve efficiency, compliance and competitiveness. The rapid adoption we are seeing indicates that our industry is ready to move beyond ‘silo’ models and into global collaborative environments".
"Society wins when medical researchers focus less on paperwork and more on patients," says Fabio Thiers, MD, PhD, ViS Research CEO. “This collaboration revamps the site feasibility assessment process. Trial planners have had to resort to creating burdensome questionnaires for researchers, because they do not have an efficient way to access and make sense of the information about locations, sites and investigators. Now they have a better option".
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.